Evidence Against Treating Post-CABG Pericarditis with Colchicine or Indomethacin
Colchicine and NSAIDs (including indomethacin) should NOT be used for asymptomatic postoperative pericardial effusions after CABG, and indomethacin is absolutely contraindicated in the immediate post-CABG setting due to increased cardiovascular thrombotic risk.
Key Contraindications and Warnings
Indomethacin: Absolute Contraindication Post-CABG
Indomethacin is explicitly contraindicated in the setting of coronary artery bypass graft (CABG) surgery 1. The FDA labeling is unequivocal on this point, stating that NSAIDs cause increased risk of serious cardiovascular thrombotic events including myocardial infarction and stroke, which can be fatal, and this risk may occur early in treatment 1.
The evidence is particularly damning:
- Two large controlled trials of COX-2 selective NSAIDs for pain treatment in the first 10-14 days following CABG found increased incidence of myocardial infarction and stroke 1
- NSAIDs increase risk of reinfarction, CV-related death, and all-cause mortality beginning in the first week of treatment 1
- In post-MI patients (similar pathophysiology to post-CABG), the incidence of death in the first year was 20 per 100 person-years in NSAID-treated patients compared to 12 per 100 person-years in non-NSAID exposed patients 1
Colchicine: Not Recommended for Postoperative Effusions
The 2015 ESC Guidelines explicitly state that colchicine is NOT recommended for postoperative effusions in the absence of systemic inflammation 2. This is a critical distinction that clinicians often miss.
The guideline specifies:
- NSAIDs are generally not indicated in asymptomatic post-surgical effusions and may be associated with increased risk of side effects 2
- The POPE trial demonstrated that diclofenac treatment of asymptomatic postoperative effusions was useless and associated with increased risk of NSAID-related side effects 2
When Treatment IS Appropriate (With Caveats)
Treatment should only be considered when there is documented post-pericardiotomy syndrome (PPS) with systemic inflammation, requiring at least 2 of 5 criteria:
- Fever without alternative causes
- Pericarditic or pleuritic chest pain
- Pericardial or pleural rubs
- Evidence of pericardial effusion
- Pleural effusion with elevated CRP 2
The demonstration of inflammatory activity is essential - simple mechanical postoperative effusions do not warrant anti-inflammatory treatment 2.
Evidence on Prophylactic Use
Colchicine for Prevention
While meta-analysis showed colchicine reduced PPS risk (OR 0.38) when used prophylactically 2, the COPPS-2 trial revealed:
- Perioperative colchicine was associated with increased gastrointestinal side effects compared to postoperative use 2
- Colchicine is not recommended for perioperative treatment and prevention of postoperative effusions in the absence of systemic inflammation 2
Indomethacin for Prevention
One study showed pre-surgery indomethacin administration was linked to PPS reduction 3, but this must be weighed against the absolute FDA contraindication for use in the CABG setting 1.
Clinical Algorithm
For asymptomatic postoperative pericardial effusions:
- Do NOT treat with colchicine or NSAIDs
- Monitor clinically
- These effusions typically resolve in 7-10 days 2
For symptomatic PPS with documented systemic inflammation:
- Avoid indomethacin entirely (contraindicated post-CABG)
- Consider aspirin (which has antiplatelet benefits already needed post-CABG) plus colchicine 2
- If NSAIDs absolutely necessary, aspirin or ibuprofen preferred over indomethacin 2
- Use lowest effective dose for shortest duration 1
Critical pitfall: Do not confuse mechanical postoperative effusions (common, benign, self-limited) with true inflammatory PPS requiring treatment. The former represents the majority of cases and treating them exposes patients to unnecessary cardiovascular and gastrointestinal risks without benefit 2.
Additional Safety Concerns
Beyond the cardiovascular risks, both agents carry significant concerns:
- Gastrointestinal bleeding risk with NSAIDs, which can be fatal and occur without warning 1
- Heart failure exacerbation with NSAIDs through fluid retention and blunting of diuretic effects 1
- Hypertension worsening with NSAID use 1
- Colchicine associated with gastrointestinal adverse events in 1.7-3% of patients 4, 2
The evidence strongly supports a conservative approach: reserve anti-inflammatory treatment for documented inflammatory PPS only, absolutely avoid indomethacin post-CABG, and recognize that most postoperative effusions are mechanical and self-limited.